Key statistics
As of last trade, Edwards Lifesciences Corp (EW:NYQ) traded at 69.78, 18.41% above the 52 week low of 58.93 set on Jul 25, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 68.64 |
---|---|
High | 71.07 |
Low | 68.64 |
Bid | 69.75 |
Offer | 69.81 |
Previous close | 68.52 |
Average volume | 7.30m |
---|---|
Shares outstanding | 602.40m |
Free float | 596.97m |
P/E (TTM) | 28.65 |
Market cap | 41.28bn USD |
EPS (TTM) | 2.39 USD |
Data delayed at least 15 minutes, as of Sep 16 2024 18:29 BST.
More ▼
- Edwards Lifesciences Completes Sale of Critical Care
- CORRECTING and REPLACING First All-Female TAVI Trial Shows Excellent Outcomes for Women Receiving Edwards Valves
- Edwards Lifesciences to Present at the 2024 Wells Fargo Healthcare Conference
- Edwards Lifesciences Reports Second Quarter Results
- Edwards Lifesciences Expands Structural Heart Portfolio With Acquisitions of JenaValve and Endotronix
- Edwards Lifesciences to Host Earnings Conference Call on July 24, 2024
- Edwards Lifesciences to Acquire Innovalve
More ▼